Asha Chaubey | Fermentation Technology | Best Researcher Award

Published on by Academic Awards

Dr. Asha Chaubey | Fermentation Technology | Best Researcher Award

CSIR-Indian Institute of Integrative MedicineΒ  | India

Dr. Asha Chaubey is a distinguished researcher at the Indian Institute of Integrated Medicine, Jammu, India, recognized for her impactful contributions in biotechnology, microbial enzymology, natural product chemistry, and biosensor development. She has authored 69 publications with over 4,460 citations and an h-index of 24, reflecting significant influence in her field. Her research encompasses microbial enzyme production and purification, including therapeutic enzymes such as L-asparaginase and serratiopeptidase, and the discovery of bioactive compounds from Himalayan Streptomyces. Dr. Asha Chaubey also pioneers in microfluidic-based nucleic acid detection platforms and miniaturized electrophoresis techniques, demonstrating innovation in molecular diagnostics. Her work spans plant molecular biology, with studies on G-protein-mediated stress and nutrient signaling, highlighting a multidisciplinary approach bridging microbiology, biotechnology, and applied molecular research. With extensive collaborations and high-impact outputs, her contributions advance both fundamental understanding and practical applications in fermentation, bioprocessing, and biosensor technology.

Profile: Scopus

Featured Publications

  • Chaubey, A., et al. (2025). Production, purification and in vitro anticancer efficiency of L-asparaginase obtained from bacterial isolate of black gram rhizospheric soil sample of J&K. Indian Journal of Agricultural Biochemistry.

  • Chaubey, A., et al. (2025). Portable, quantitative, real-time isothermal nucleic acid amplification test using microfluidic device-coupled UV-LED photodiode detector. Biosensors and Bioelectronics.

  • Chaubey, A., et al. (2025). (3R)-obscurolide A: A new obscurolide from Streptomyces chartreusis SA-7 isolated from soil of the North Western Himalayas. Natural Product Research.

  • Chaubey, A., et al. (2024). Miniaturized electrophoresis: An integrated microfluidic cartridge with functionalized hydrogel-assisted LAMP for sample-to-answer analysis of nucleic acid. Biomicrofluidics.

  • Chaubey, A., et al. (2024). Pea G-protein Ξ³ subunits: Unlocking their potential in physiological stress and mycorrhizal mediated nutrient sensing. Current Plant Biology.

 

Xi Peng Ren | Soil microbiota | Best Researcher Award

Published on by Academic Awards

Mr. Xi Peng Ren | Soil microbiota | Best Researcher Award

PhD candidate, Central Queensland University, China

Xipeng Ren is a Ph.D. candidate at Central Queensland University, Australia, with a Master’s in Biotechnology from the University of Queensland. His research focuses on microbiota, including microbial genomics, animal intestinal health, soil microbiota, and plant-microbe interactions. He is involved in projects on soil microbiome restoration and alternative antibiotics for poultry. Xipeng has contributed to several publications on microbial dynamics, soil health, and animal welfare. Skilled in bioinformatics, molecular biology, and lab techniques, he is fluent in English and collaborates widely in his research. πŸŒ±πŸ“šπŸ§¬πŸŒΎ

Publication Profile

Google Scholar

Educational Background πŸŽ“πŸŒ

Xipeng Ren is currently pursuing a Ph.D. at Central Queensland University, Australia, from January 2021 to December 2024. Prior to this, he earned a Master of Biotechnology from the University of Queensland, Australia, in July 2020. His academic journey began with a Bachelor’s degree in Biological Science from Inner Mongolia University, China, completed in July 2017. Xipeng’s educational experiences across diverse institutions have equipped him with a solid foundation in microbiology, biotechnology, and biological sciences, laying the groundwork for his cutting-edge research in microbiota and environmental health. πŸŒΏπŸ”¬πŸŽ“

Research Interests πŸ”¬πŸŒ±

Xipeng Ren’s research interests lie in the fascinating field of microbiota, where he explores microbial genomics, transcriptomics, and metabolism. His work delves into the health of animal intestines, particularly in poultry and livestock, as well as microbial flora. Additionally, he investigates soil microbiota, its metabolism, and the intricate interactions between plants and soil microbes. With a strong focus on microbial protection, his research also incorporates statistics and bioinformatics, utilizing advanced techniques to better understand the microbial ecosystems that are essential for both animal and environmental health. πŸ¦ πŸŒΎπŸ“Š

Research Focus 🧬🌱

Xipeng Ren’s research spans several critical areas in microbiota science, including soil microbiome restoration, plant-microbe interactions, and animal intestinal health. His work focuses on using phytogenic products to address pasture dieback, enhance soil health, and improve agricultural productivity. Ren’s studies also explore microbial genomics, transcriptomics, and metabolism, particularly in the context of livestock and poultry gut health. His efforts extend to microbiota-based solutions for animal welfare, antibiotic resistance, and productivity. This interdisciplinary research blends microbiology, bioinformatics, and environmental sustainability to develop innovative solutions for agriculture and livestock health. πŸŒΎπŸ„πŸ¦ 

Publication Top Notes

  • Remediation of pasture dieback using plant growth promotant – Cited by: 7, Year: 2022 🌱
  • Humate application alters microbiota–mineral interactions and assists in pasture dieback recovery – Cited by: 5, Year: 2023 🌾
  • Sea minerals reduce dysbiosis, improve pasture productivity and plant morphometrics in pasture dieback affected soils – Cited by: 5, Year: 2022 🌊
  • Phytogenic supplement containing menthol, carvacrol and carvone ameliorates gut microbiota and production performance of commercial layers – Cited by: 5, Year: 2022 🦠
  • Application of phytogenic liquid supplementation in soil microbiome restoration in Queensland Pasture Dieback – Cited by: 3, Year: 2023 🌿
  • The role of microbiota in animal health and productivity: misinterpretations and limitations – Cited by: 3, Year: 2022 πŸ„
  • Enhancing soil health and carbon sequestration through phytogenic treatment: insights into microbial functional pathways in pasture dieback affected soil – Cited by: 2, Year: 2024 🌍
  • Ileum transcriptional response to prolonged supplementation with phytogenic product containing menthol, carvacrol and carvone – Cited by: 2, Year: 2022 🐦
  • Unveiling Microbial Dynamics and Gene Expression in Legume–Buffel Grass Coculture Systems for Sustainable Agriculture – Cited by: 2, Year: 2024 🌱
  • Transcriptomic Insights: Phytogenic Modulation of Buffel Grass (Cenchrus ciliaris) Seedling Emergence – Cited by: 2, Year: 2024 🌾

Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Published on by Academic Awards

Assist Prof Dr. Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Assist Prof Dr. Khalid Abd El Ghany, Egyption Drug Authoriity, Egypt

Dr. Khalid Abd El Ghany is a Post-Approval Control Manager at the Egyptian Drug Authority (since 2021) with over two decades of experience in the pharmaceutical sector. He holds a Ph.D. in Genetic Engineering and Biotechnology from Al-Sadat City University (2018) and has completed post-doctoral research at the Egyptian Drug Authority. He is a skilled researcher with numerous publications and expertise in microbial biotechnology. A recipient of the Egyptian Drug Authority Hero’s Certificate (2022) and the Ideal Pharmacist Award (2016), Dr. Khalid is also active in social initiatives, holding leadership roles in various organizations. πŸ“šπŸŒ

 

Publication profile

Google Scholar

Education Background

Dr. Khalid Abd El Ghany has a distinguished educational background in pharmacy and biotechnology. He earned his B.Sc. in Pharmacy with honors from Al-Azhar University, Egypt, in 1994. Later, he pursued an M.Sc. in Microbial Biotechnology from Al-Sadat City University (2012-2014), further advancing his expertise with a Ph.D. in Genetic Engineering and Biotechnology from the same institution in 2018. Since 2020, he has been a post-doctoral researcher at the Egyptian Drug Authority, where he continues to contribute to the field of microbial biotechnology. πŸ“˜πŸ”¬

 

Professional Experience

Dr. Khalid Abd El Ghany has extensive experience in pharmaceutical regulation and management. Since 2021, he has served as the Post-Approval Control Manager at the Egyptian Drug Authority (EDA). From 2017 to 2021, he was the Deputy Head of the Inspection Department at NODCAR, where he also worked in the Microbiology Lab from 2012 to 2017. His career began as a pharmacist at Arab Drug Company (1995-1996), followed by years in the private pharmaceutical sector, where he was the owner and director from 1996 to 2011. πŸŒŸπŸ”¬

 

Research Focus

Dr. Khalid Abd El Ghany’s research is primarily centered on microbial biotechnology and genetic engineering. His work involves probiotics, especially Lactobacillus acidophilus, in cancer treatment and antioxidant activities. He also focuses on vaccine design, integrating immunoinformatics and cheminformatics to target pathogens like Klebsiella pneumoniae and Pseudomonas aeruginosa. Additionally, Dr. Khalid has contributed to studies on Ξ²-glucan production, antimicrobial agents, and the potential of probiotics against viral infections, including COVID-19. His work is diverse, covering biotechnology, immunology, and pharmaceutical sciences. πŸ§¬πŸ’‰

 

Conclusion

With his strong academic background, significant experience in pharmaceutical regulation, a proven track record in research, and leadership in social initiatives, Assist. Prof. Dr. Khalid Abd El Ghany is a strong candidate for the Best Researcher Award. His dedication to both scientific advancement and community service makes him a well-rounded contender for this recognition.

 

Publication Top Notes

  • A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice – 43 citations (2015) πŸ“‘πŸ§¬
  • In Silico Designing of a Multitope Vaccine against Rhizopus microsporus – 26 citations (2021) πŸ’‰πŸ–₯️
  • Evaluation of antioxidant and antitumor activities of Lactobacillus acidophilus bacteria – 20 citations (2014) πŸ§ͺ🦠
  • Screening and molecular identification of lactic acid bacteria producing Ξ²-glucan – 13 citations (2022) 🧬🍏
  • Description of isolated LAB producing Ξ²-glucan and evaluation of its therapeutic effect – 11 citations (2016) 🧫🩺
  • Integration of Immunoinformatics and Cheminformatics for Vaccine Design – 5 citations (2023) πŸ§¬πŸ’‰
  • Molecular Characterization and Optimization of Ξ²-Glucan Production from Pediococcus parvulus – 3 citations (2018) πŸ§¬πŸ“Š
  • Lactiplantibacillus plantarum and Saussurea costus as Therapeutic Agents – 2 citations (2023) πŸ§¬πŸ’Š
  • Role of probiotic bacteria against virus pathogenesis: Defence against COVID-19 – 1 citation (2024) 🦠🧬
  • Efficacy of Ξ²-glucan in an acute model of diabetes – 1 citation (2022) πŸ©ΊπŸ“Š
  • Synthesis, Molecular Docking Studies of Pyrazolo[1,5-a]pyrimidines – 2023 πŸ“‘βš—οΈ